EUVIMEDEUVIMED entdecken
Crossref

Experimental Validation and Multimodal Spectroscopic Profiling of the Neuroprotective Potential of Costunolide in Chemotherapy‐Induced Neuropathic Pain

Omeyya Tanveer, Yeju Lee, Sana Zafar, Muhammad Ibrar Khan, Amber Sani, Zahid Raza, Raja Shahamad Tanveer, Rimsha Noor, Kifayat Ullah Shah, Fakhar Ud Din iD, Hussain Ali, Eun Kyoung Seo und 1 weitere

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Omeyya Tanveer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Pharmacological Sciences Research Lab, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan. Hauptthemen laut MEDLINE: Neuralgia, Neuroprotective Agents, Sesquiterpenes, Paclitaxel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain is a complex chronic condition resulting from injury to the nerve. Paclitaxel (PTX) is a commonly used chemotherapeutic drug, but it is usually associated with peripheral neuropathy. Costunolide (COS), a bioactive sesquiterpene lactone, exhibits potent neuroprotective, anti‐inflammatory, antioxidant, and anti‐apoptotic properties. The current study aimed to investigate the efficacy of COS in attenuating PTX‐induced neuropathic pain using advanced spectroscopic, histological and biochemical analyses. Findings from the study revealed that administration with COS significantly improved the pain parameters, including mechanical allodynia, thermal hyperalgesia, and cold allodynia by increasing the pain thresholds. Muscle strength and motor coordination also improved significantly following administration of COS. Results from the Raman spectral analysis revealed distinct PTX‐induced biochemical disruptions, especially in the lipids and proteins, which were subsequently normalized by COS. FTIR spectra demonstrated that COS mitigated PTX‐induced damage to the myelin sheath, hence preserving the biochemical integrity. The tissue oxygenation (StO 2 ) profile was also improved. COS preserved neuronal architecture, reduced PTX‐induced apoptosis, and maintained spinal cord and sciatic nerve structure. It also increased the level of antioxidants, that is, GSH, GST, and catalase, while reducing the level of oxidative stress markers (MPO, EPO, LPO, NO). Together, these findings establish COS as a promising candidate for the treatment of peripheral neuropathy. Its multimodal protective mechanisms—captured at both molecular and cellular levels‐ highlight its potential to counteract PTX‐induced neurotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaNeuroprotective AgentsSesquiterpenesPaclitaxelAnimalsRatsMaleRats, Sprague-DawleyOxidative StressLactones

Stichwörter der Autor:innen

DRSFTIRRaman spectroscopyantioxidantanti‐inflammatorycostunolideneuropathic pain

Substanzen

Neuroprotective AgentsSesquiterpenescostunolidePaclitaxelLactones

Autor:innen und Institutionen

  • Department of Pharmacy, Pharmacological Sciences Research Lab, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
  • Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
  • College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South Korea.
  • Department of Pharmacology, Faculty of Pharmacy, Capital University of Science & Technology, Islamabad, Pakistan.
  • Govt. Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan.
  • Department of Pharmacy, Nanomedicine Research Group, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

ORCID-Profile: Fakhar Ud Din

Förderung

  • National Research Foundation of Korea (NRF)

Zitieren

APA

Tanveer, O., Lee, Y., Zafar, S., Khan, M. I., Sani, A., Raza, Z., Tanveer, R. S., Noor, R., Shah, K. U., Din, F. U., Ali, H., Seo, E. K., & Khan, S. (2026). Experimental Validation and Multimodal Spectroscopic Profiling of the Neuroprotective Potential of Costunolide in Chemotherapy‐Induced Neuropathic Pain. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70718

Vancouver

Tanveer O, Lee Y, Zafar S, Khan MI, Sani A, Raza Z, et al. Experimental Validation and Multimodal Spectroscopic Profiling of the Neuroprotective Potential of Costunolide in Chemotherapy‐Induced Neuropathic Pain. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70718

BibTeX
@article{Tanveer2026,
  author = {Tanveer, Omeyya and Lee, Yeju and Zafar, Sana and Khan, Muhammad Ibrar and Sani, Amber and Raza, Zahid and Tanveer, Raja Shahamad and Noor, Rimsha and Shah, Kifayat Ullah and Din, Fakhar Ud and Ali, Hussain and Seo, Eun Kyoung and Khan, Salman},
  title = {Experimental Validation and Multimodal Spectroscopic Profiling of the Neuroprotective Potential of Costunolide in Chemotherapy‐Induced Neuropathic Pain},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70718}
}
Kostenlos starten →